CHROMOSOME ABNORMALITIES IN ORAL CONTRACEPTIVE BREAKTHROUGH PREGNANCIES
- 23 June 1979
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 313 (8130), 1342-1343
- https://doi.org/10.1016/s0140-6736(79)91969-x
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Role of Oral Contraception in Congenital Malformations of OffspringInternational Journal of Epidemiology, 1978
- Physiologic factors affecting pulmonary artery pressure in infants with persistent pulmonary hypertensionThe Journal of Pediatrics, 1978
- Oral Contraceptives and Birth DefectsNew England Journal of Medicine, 1978
- Persistent pulmonary hypertension of the newborn infantThe Journal of Pediatrics, 1976
- Neonatal hypoxia and pulmonary vasospasm: Response to tolazolineThe Journal of Pediatrics, 1976
- THE OUTCOME OF PREGNANCY IN FORMER ORAL CONTRACEPTIVE USERSBJOG: An International Journal of Obstetrics and Gynaecology, 1976
- Relationship of Tumor Immunogenicity to Concentration of the Oncogen2JNCI Journal of the National Cancer Institute, 1975
- The Immune Reaction as a Stimulator of Tumor GrowthScience, 1972
- Maternal-foetal incompatibility associated with the H-3 locus in the mouseHeredity, 1969
- Effects of tolazoline hydrochloride (priscoline) on circulatory dynamics of patients with pulmonary hypertensionAmerican Heart Journal, 1958